Miv Therapeutics, Inc. (IVT) Tops Q1 EPS by 7c

Miv Therapeutics, Inc. (NYSE: IVT) reported Q1 EPS of $0.04, $0.07 better than the analyst estimate of ($0.03).

For earnings history and earnings-related data on Miv Therapeutics, Inc. (IVT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c